← Back to screener

Progyny, Inc. PGNY

Rank #1040 · Nasdaq · $2.3B market cap
Audited by Ernst & Young LLP, no going-concern flag in the latest filing.
Score
54.4
P/E
36.9
P/B
6.07
ROE
16.5%
Op. Margin
5.7%
Debt Ratio
49%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★☆☆☆
Average

P/E 36.9x, P/B 6.07x. Ranks in the top 58% of the universe.

Profitability ★★★☆☆
Average

ROE 16.5%. Ranks in the top 43% of the universe.

Safety ★★★★☆
Good

Debt ratio 49%. Ranks in the top 23% of the universe. Under 100% is generally considered a safe level.

Growth ★★★★★
Excellent

Revenue growth of 38.3% year over year. Ranks in the top 9% of the universe.

Growth is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2019$0.0B$-0.0B$-0.0B$-0.1B-22.7-31
2020$0.1B$-0.0B$0.0B$-0.1B-3.3-37
2021$0.2B$0.0B$-0.0B$-0.1B4.2-91
2022$0.3B$0.0B$0.0B$0.1B2.493
2023$0.5B$0.0B$0.1B$0.2B6.599
2024$0.8B$0.0B$0.0B$0.3B3.081
2025$1.1B$0.1B$0.1B$0.4B5.749

← See the full screener